J&J Units Hit Mylan With IP Suit Over Concerta Generic Bid

J&J Units Hit Mylan With IP Suit Over Concerta Generic Bid

Two Johnson & Johnson units filed a patent suit against drugmaker Mylan Inc. in Delaware federal court on Monday, alleging Mylan's bid to market a generic version of the Concerta attention-deficit hyperactivity disorder medication violates its ...read more

  • Tags: